gilteritinib FLT3 Codon 835 Missense, +4 more biomarkers Acute Myeloid Leukemia Relapse/refractory gilteritinib targeted therapy
midostaurin + cytarabine + daunorubicin FLT3 Codon 835 Missense, +4 more biomarkers Acute Myeloid Leukemia Newly diagnosed Consolidation, +1 more context cytarabine, +2 more drugs chemotherapy, +1 more type
gilteritinib FLT3 Codon 835 Missense, +4 more biomarkers Acute Myeloid Leukemia Relapse/refractory gilteritinib targeted therapy
midostaurin + cytarabine FLT3 Codon 835 Missense, +4 more biomarkers Acute Myeloid Leukemia Newly diagnosed Consolidation cytarabine, +1 more drug chemotherapy, +1 more type
midostaurin + cytarabine + daunorubicin FLT3 Codon 835 Missense, +4 more biomarkers Acute Myeloid Leukemia Newly diagnosed Induction cytarabine, +2 more drugs chemotherapy, +1 more type
sorafenib FLT3 ITD Acute Myeloid Leukemia Stable disease/remission Maintenance sorafenib targeted therapy
sorafenib + (azacitidine or decitabine) FLT3 ITD Acute Myeloid Leukemia Relapse/refractory azacitidine, +2 more drugs chemotherapy, +1 more type
sorafenib + (azacitidine or decitabine) FLT3 ITD Acute Myeloid Leukemia Newly diagnosed Induction azacitidine, +2 more drugs chemotherapy, +1 more type
Cancer Search
